|Articles|August 1, 2003

Pharmacy Times

  • Volume 0
  • 0

Death More Prevalent in RA Patients

Patients with rheumatoid arthritis (RA) have a shortened life expectancy because of an increased risk to lung and hematopoi-etic malignancies, circulatory disorders, and cerebrovascular causes, according to the results of a 20-year study. Researchers in England and Scotland conducted a large population-based cohort study to determine specific mortality incidence in >40,000 people with RA and other rheumatic conditions. The participants were followed for 20 years following their initial hospital admission.

The results showed that RA patients had the greatest number of deaths, and those with systemic sclerosis had the highest risk of death. Death was more prevalent in the first 5 years after hospitalization. For RA patients, the greatest risk was seen in diseases associated with the musculoskeletal system and connective tissues?a 60-fold increased risk in men and a 28-fold increase in women.

Articles in this issue

about 22 years ago

Competition for the Tooth Fairy

about 22 years ago

Healthy Mouth, Healthy Body

about 22 years ago

Puberty's Role in Breast Cancer

about 22 years ago

Supplements Do Not Enlarge Breasts

about 22 years ago

Seniors Need Extra Dental Care

about 22 years ago

Men Not Up to Par with Women

about 22 years ago

Look to the Taste Buds

about 22 years ago

MRI Shows Course of RA

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


Latest CME